ASND (Ascendis Pharma AS) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma AS ROE % Adjusted to Book Value?

Ascendis Pharma AS's ROE % for the quarter that ended in Dec. 2024 was 0.00%. Ascendis Pharma AS's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Ascendis Pharma AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Ascendis Pharma AS ROE % Adjusted to Book Value Historical Data

The historical data trend for Ascendis Pharma AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS ROE % Adjusted to Book Value Chart

Ascendis Pharma AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-6.89

-5.60

-3.87

Ascendis Pharma AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Ascendis Pharma AS's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Ascendis Pharma AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's ROE % Adjusted to Book Value falls into.

Ascendis Pharma AS ROE % Adjusted to Book Value Calculation

Ascendis Pharma AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Ascendis Pharma AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Ascendis Pharma AS ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (NAS:ASND) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.